Home Search Abstracts Browse Sessions Program Committee View Session E-mail Abstract Author

 

 




Session 59 Poster Abstracts
Pathogenesis of Primary HIV Infection
Thursday, 1:30 - 3:30 pm
Hall D


286    
Early Proliferation and Apparent Loss of CCR5+ CD38+++ Antigen-Specific CD4+ Th1 Effector Cells during Primary HIV-1 Infection
J Zaunders*1, D Kaufmann2, M Munier3, S Ip3, P Grey3, D Smith3, T Ramacciotti3, D Quan4, R Finlayson5, J Kaldor3, E Rosenberg2, B Walker2, D Cooper3, A Kelleher3, and Phaedra Study Team
1St Vincent's Hosp, Sydney, Australia; 2Massachusetts Gen Hosp, Boston, USA; 3Univ of New South Wales, Sydney, Australia; 4Holdsworth House Gen Practice, Sydney, Australia; and 5Taylor Square Private Clin, Sydney, Australia

Background:  Antigen-specific CD4+ T cells are believed to be generated during primary HIV-1 infection (PHI), but lost early in the course of infection. We recently found, in a long-term non-progressor, that HIV-specific CD4+ T cells expressed CCR5. These cells were also cytotoxic T lymphocytes (CTL). Therefore, we investigated whether we could detect HIV-specific CCR5+ CD4+ CTL during PHI.

Methods:  Fresh blood samples were obtained from 33 subjects enrolling in the Phaedra observational study of PHI. Subgroups were defined as early PHI (< 22 days following onset of symptoms; n = 21) or late PHI (28 to 122 days; n = 12). CD4+ T cells expressing CCR5 plus markers of activation (CD38), CTL (TIA-1, Granzyme B, Perforin), proliferation (Ki-67), and cell survival (Bcl-2) were analyzed by 6-color flow cytometry. The results were compared with 14 HIV-negative controls. Antigen-specific CD4+ T cells were measured in the last 14 consecutive PHI subjects (7 early and 7 late) by intracellular cytokine assay following incubation with HIV-1 Gag peptide pools.

Results:  CCR5+CD38+++ CD4+ T cells were significantly elevated during early PHI, compared with late PHI and controls (medians: 4.8 vs 0.9 vs 0.3%, respectively). Also significantly elevated were CCR5+TIA-1+Ki-67+ CD4+ T cells (3.1 vs 0.9 vs 0.2%, respectively) and Perforin+GranzymeB+ CD4+ CTL (11.6 vs 5.0 vs 1.6%). For all comparisons between early PHI subjects and controls, or between early and late PHI, p values were < 0.001 and <0.01, respectively. HIV-1 Gag-specific IFN-γ-producing CD4+ T cells were readily detected in early PHI, compared with late PHI (medians: 0.58% vs 0.08%, respectively). These cells were predominantly CD38+++Bcl-2low, TIA-1+Ki-67+, and CD40L+, while approximately 20% of IFN-γ+ cells also produced IL-2 and were IL-7R+. A very strong correlation was noted between the proportions of Gag-specific and CCR5+CD38+++ CD4+ T cells at all stages of PHI (R2 = 0.85). Further analysis of CCR5+CD38+++ CD4+ T cells in early PHI showed an increased expression of CXCR3 and IL-12Rß1, consistent with Th1 effector cells. Limited expression of IL-2, IL-7R, and CCR7 by this population suggests it also contains precursors of central memory cells.

Conclusions:  These results suggest that the very early antiviral response in HIV-1 infection includes proliferating, highly activated CCR5+CD4+ effector cells, which are susceptible to both apoptosis and cytopathic infection with HIV-1, and rapidly decline.

Keywords: CD4; Antigen-specific ; CCR5